Compare BioLum Sciences vs Circassia Pharmaceuticals
Customers evaluate the quality of BioLum Sciences's products using the following success metrics.
Overview
BioLum Sciences is 9 yrs old and is based in United States.
BioLum Sciences specializes in bioanalytical chemistry and assay development for chronic diseases. It develops a medical device, BioSense AMD (airway monitoring device), that aids in the diagnosis and monitoring of respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD) by enabling patients to measure airway inflammation with a quick test. It was founded in 2015 and is based in Houston, Texas.
Circassia Pharmaceuticals is 18 yrs old and is based in United Kingdom.
Circassia Pharmaceuticals is a specialty pharmaceutical company with a portfolio of respiratory products. Its proprietary technologies are designed to develop a range of therapies for asthma and chronic obstructive pulmonary disease. Its NIOX products are used to help improve asthma management.
Demo Video
Leadership
Edward Allegra (Founder, Chief Executive Officer)
Michael Roller (Chief Financial Officer)
Funding
Investors
National Science Foundation, Bayer G4A
CIP Merchant Capital
Product
Why BioLum Sciences beats Circassia Pharmaceuticals
Information not available because Circassia Pharmaceuticals has not claimed their profile.
Work for Circassia Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Circassia Pharmaceuticals?
Claim your profile now.
Benefits
- Selectivity
- Sensitivity
- Calibration Curves
Products
VeNO
Chemiluminescent assay kit for Vascular endogenous nitric oxide detection
Customers
Known Partners
Why They Buy